Male androgenetic alopecia aged 18-60 years Male androgenetic alopecia, topical finasteride, videodermoscope
Conditions
Interventions
Topical finasteride 0.5% solution once daily ,Topical finasteride 0.5% solution twice daily
Experimental Drug,Experimental Drug
Topical finasteride 0.5% solution once daily,Topical finasteride 0.5% solution twice daily
Sponsors
Faculty of Medicine, Srinakharinwirot University
Eligibility
Sex/Gender
Male
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Male androgenetic alopecia aged 18-60 years Norwood-Hamilton classification type III vertex to V
Exclusion criteria
Exclusion criteria: 1. History of male sexual problems 2. Underlying diseases of hepatitis, kidney disease, cardiovascular disease 3. History of depression, or suicidal idea 4. On the treatment of androgenetic alopecia within 6 months 4. Drug allergy to finasteride
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total Hair density 24 weeks hairs/cm2 | — |
Secondary
| Measure | Time frame |
|---|---|
| Terminal Hair Density 24 weeks hairs/cm2,Non-terminal Hair Density 24 weeks hairs/cm2,Hair Diameter 24 weeks micrometer,Global Photography Assessment by 2 Independent Dermatologists 24 weeks 7-point scales ,Patient Satisfaction 24 weeks Visual Analogue Scales | — |
Countries
Thailand
Contacts
Public ContactSaranya Khunkhet
Department of Dermatology, Faculty of Medicine, Srinakharinwirot University
Outcome results
None listed